Ling Yan

497 total citations
18 papers, 353 citations indexed

About

Ling Yan is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Ling Yan has authored 18 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Cancer Research and 6 papers in Molecular Biology. Recurrent topics in Ling Yan's work include Cancer, Lipids, and Metabolism (5 papers), Inflammatory Biomarkers in Disease Prognosis (4 papers) and RNA modifications and cancer (3 papers). Ling Yan is often cited by papers focused on Cancer, Lipids, and Metabolism (5 papers), Inflammatory Biomarkers in Disease Prognosis (4 papers) and RNA modifications and cancer (3 papers). Ling Yan collaborates with scholars based in China, Singapore and United States. Ling Yan's co-authors include Hailun Xie, Jialiang Gan, Guo‐Tian Ruan, Yizhen Gong, Feng Gao, Elena G. Seviour, Xinghua Liu, Lin Ye, Bo Zhang and Shuangyi Tang and has published in prestigious journals such as Scientific Reports, Annals of Oncology and Cancer Letters.

In The Last Decade

Ling Yan

17 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ling Yan China 11 125 104 93 87 78 18 353
David Santos Spain 13 60 0.5× 140 1.3× 47 0.5× 115 1.3× 160 2.1× 36 475
Ruiyu Wang China 14 69 0.6× 169 1.6× 41 0.4× 58 0.7× 36 0.5× 42 379
Andrew Lemieux United States 6 102 0.8× 61 0.6× 94 1.0× 25 0.3× 148 1.9× 6 340
Susumu Takagi Japan 6 56 0.4× 164 1.6× 45 0.5× 54 0.6× 119 1.5× 11 464
Matthew Kahn United Kingdom 12 36 0.3× 156 1.5× 78 0.8× 47 0.5× 68 0.9× 22 437
J Wysocki France 8 50 0.4× 166 1.6× 73 0.8× 38 0.4× 72 0.9× 15 375
Taiki Ohashi Japan 9 50 0.4× 112 1.1× 164 1.8× 34 0.4× 67 0.9× 13 424
Kuniyoshi Fukai Japan 7 19 0.2× 246 2.4× 142 1.5× 60 0.7× 117 1.5× 13 511
Zirong Lan China 8 25 0.2× 229 2.2× 36 0.4× 158 1.8× 46 0.6× 18 491

Countries citing papers authored by Ling Yan

Since Specialization
Citations

This map shows the geographic impact of Ling Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Yan more than expected).

Fields of papers citing papers by Ling Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Yan. The network helps show where Ling Yan may publish in the future.

Co-authorship network of co-authors of Ling Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Ling Yan. A scholar is included among the top collaborators of Ling Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Yan. Ling Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Gong, Yizhen, Hui Ma, Guo‐Tian Ruan, et al.. (2021). Diagnosis and prognostic value of C-X-C motif chemokine ligand 1 in colon adenocarcinoma based on The Cancer Genome Atlas and Guangxi cohort. Journal of Cancer. 12(18). 5506–5518. 5 indexed citations
3.
Ruan, Guo‐Tian, Shuai Wang, Xiwen Liao, et al.. (2021). Investigation and verification of the clinical significance and perspective of natural killer group 2 member D ligands in colon adenocarcinoma. Aging. 13(9). 12565–12586. 4 indexed citations
4.
Feng, Mei, et al.. (2021). 882P Initial analyses of anti-PD-1 antibody plus chemoradiotherapy in patients with recurrent or metastatic head and neck cancer. Annals of Oncology. 32. S795–S795. 1 indexed citations
5.
Ruan, Guo‐Tian, Yizhen Gong, Feng Gao, et al.. (2020). <p>The Perspective of Diagnostic and Prognostic Values of Lipoxygenases mRNA Expression in Colon Adenocarcinoma</p>. OncoTargets and Therapy. Volume 13. 9389–9405. 10 indexed citations
6.
Wang, Shengqiang, Hailun Xie, Yizhen Gong, et al.. (2020). The value of L3 skeletal muscle index in evaluating preoperative nutritional risk and long-term prognosis in colorectal cancer patients. Scientific Reports. 10(1). 8153–8153. 49 indexed citations
7.
Liu, Junqi, Xiwen Liao, Xiangkun Wang, et al.. (2020). Prognostic value of Glypican family genes in early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy and possible mechanisms. BMC Gastroenterology. 20(1). 415–415. 13 indexed citations
8.
9.
Gong, Yizhen, Hailun Xie, Ling Yan, et al.. (2020). The prognostic value of preoperative serum CA724 for CEA-normal colorectal cancer patients. PeerJ. 8. e8936–e8936. 13 indexed citations
10.
Xie, Hailun, et al.. (2020). The prognostic value of combined tumor markers and systemic immune-inflammation index in colorectal cancer patients. Langenbeck s Archives of Surgery. 405(8). 1119–1130. 13 indexed citations
11.
Xie, Hailun, Yizhen Gong, Ling Yan, et al.. (2020). Computed Tomography–Determined Sarcopenia Is a Useful Imaging Biomarker for Predicting Postoperative Outcomes in Elderly Colorectal Cancer Patients. Cancer Research and Treatment. 52(3). 957–972. 38 indexed citations
12.
Yan, Ling, Yizhen Gong, Guo‐Tian Ruan, et al.. (2020). Distinct diagnostic and prognostic values of γ‑aminobutyric acid type A receptor family genes in patients with colon adenocarcinoma. Oncology Letters. 20(1). 275–291. 29 indexed citations
13.
14.
Ruan, Guo‐Tian, Yizhen Gong, Xiwen Liao, et al.. (2019). The diagnosis and prognosis values of WNT mRNA expression in colon adenocarcinoma. Journal of Cellular Biochemistry. 121(5-6). 3145–3161. 16 indexed citations
15.
Yan, Ling, et al.. (2019). Prognostic value of chloride channel accessory mRNA expression in colon cancer. Oncology Letters. 18(3). 2967–2976. 7 indexed citations
16.
Zhang, Fang, et al.. (2016). Progress in research of esophageal granular cell tumors. World Chinese Journal of Digestology. 24(17). 2647–2647.
17.
Ye, Lin, et al.. (2011). Monoacylglycerol lipase (MAGL) knockdown inhibits tumor cells growth in colorectal cancer. Cancer Letters. 307(1). 6–17. 101 indexed citations
18.
Luo, Chunli, et al.. (2010). Expression of hepaCAM and Its Effect on Proliferation of Tumor Cells in Renal Cell Carcinoma. Urology. 75(4). 828–834. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Santos Breakdown of academic impact, for papers by Ruiyu Wang Breakdown of academic impact, for papers by Andrew Lemieux Breakdown of academic impact, for papers by Susumu Takagi Breakdown of academic impact, for papers by Matthew Kahn Breakdown of academic impact, for papers by J Wysocki Breakdown of academic impact, for papers by Taiki Ohashi Breakdown of academic impact, for papers by Kuniyoshi Fukai Breakdown of academic impact, for papers by Zirong Lan
Rankless by CCL
2026